HGF and diabetic neuropathy: It is interesting to note that in patients taking calcium channel blockers such as pregabalin and/or gabapentin used as first-line treatments for diabetic neuropathy, the pain-reducing effect of plasmid DNA designed to express human HGF was significantly reduced in clinical trials [19,30].